Showing results (611-620 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|September 22, 2015
Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysisAn Pan, Yeli Wang, Mohammad Talaei, et al.
The Lancet. Diabetes & Endocrinology|September 15, 2014
Diabetes in China: a societal solution for a personal challengeJuliana C N Chan, Yuying Zhang, Guang Ning
The Lancet. Diabetes & Endocrinology|August 8, 2014
Diagnosis and management of adrenal insufficiencyIrina Bancos, Stefanie Hahner, Jeremy Tomlinson, et al.
The Lancet. Diabetes & Endocrinology|August 2, 2014
Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohortRoseanne O Yeung, Yuying Zhang, Andrea Luk, et al.
The Lancet. Diabetes & Endocrinology|July 17, 2017
Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trialAaron Baum, Joseph Scarpa, Emilie Bruzelius, et al.
The Lancet. Diabetes & Endocrinology|November 6, 2017
Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trialsPhilippe Autier, Patrick Mullie, Alina Macacu, et al.
The Lancet. Diabetes & Endocrinology|November 6, 2017
Cardiovascular risk factors and carotid intima media thickness in young adults born small for gestational age after cessation of growth hormone treatment: a 5-year longitudinal studyManouk van der Steen, Gerthe F Kerkhof, Carolina C J Smeets, et al.
The Lancet. Diabetes & Endocrinology|October 17, 2017
Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studiesJason H Y Wu, Matti Marklund, Fumiaki Imamura, et al.
The Lancet. Diabetes & Endocrinology|September 18, 2017
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trialOlga Vaccaro, Maria Masulli, Antonio Nicolucci, et al.
The Lancet. Diabetes & Endocrinology|August 29, 2017
Aiding sleep in type 2 diabetes: therapeutic considerationsXiao Tan, Lieve van Egmond, Colin D Chapman, et al.
Pageof 93